Hypoparathyroidism Treatment Market Size & Share 2024 – 2032
Market Size by Product Type (Supplements [Calcium, Vitamin D, Magnesium, Zinc], Parathyroid Hormone), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) & Forecast.
Report ID: GMI8302
|
Published Date: February 2024
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Hypoparathyroidism Treatment Market Size
Hypoparathyroidism Treatment Market was valued at USD 1.3 billion in 2023 and is estimated to register a CAGR of 6.9% from 2024 to 2032. The market has witnessed significant growth over the recent years, driven by the increasing cases of hypoparathyroid disorders, rising number of thoracic surgeries and thyroid gland disorders, and increasing cases of thyroid cancer worldwide. Additionally, advancements in diagnostic technologies are enabling more accurate and timely diagnosis of hypoparathyroidism, leading to a higher number of patients seeking treatment. Further, growing awareness among healthcare professionals and patients about the importance of early detection and treatment is driving market growth by encouraging more proactive management of hypoparathyroidism.
Hypoparathyroidism Treatment Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Hypoparathyroidism is a rare endocrine disorder characterized by insufficient production or secretion of parathyroid hormone (PTH) by the parathyroid glands. These small glands are located in the neck, behind the thyroid gland, and play a crucial role in regulating calcium and phosphorus levels in the body. This imbalance disrupts various physiological processes in the body, affecting the muscles, nerves, and bones.
Hypoparathyroidism Treatment Market Trends
However, the high cost of treatment can impose a significant financial burden on patients and their families. Consequently, due to financial constraints, some individuals delay seeking medical attention or avoid necessary tests and treatments for hypoparathyroidism, thereby impeding market growth to some extent.
Hypoparathyroidism Treatment Market Analysis
Based on the product type, the global hypoparathyroidism treatment industry is segmented into supplements and parathyroid hormone. The supplements segment is further divided into calcium supplements, vitamin D supplements, and other supplements. The supplements segment garnered USD 888.2 million revenue in the year 2023.
Based on the route of administration, the global hypoparathyroidism treatment market is classified into oral and parenteral. The oral route segment dominated the market and accounted for 66.5% market share in the year 2023.
Based on distribution channel, the global market is divided into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominated the market and is expected to reach USD 1 billion by 2032.
North America hypoparathyroidism treatment market is expected to grow at 6.8% CAGR during the analysis period.
Hypoparathyroidism Treatment Market Share
The hypoparathyroidism treatment industry is characterized by a dynamic interplay among pharmaceutical companies striving to capture a significant share. Companies such as Takeda Pharmaceutical Company Ltd., Ascendis Pharma, and F. Hoffman-La Roche Ltd. are notable players, with well-established product portfolios. These players are constantly involved in strategic alliances, collaborations, and market expansion initiatives to strengthen their foothold in the market.
Hypoparathyroidism Treatment Market Companies
Market players operating in the hypoparathyroidism treatment are as mentioned below:
Hypoparathyroidism Treatment Industry News:
The global hypoparathyroidism treatment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product Type
Market, By Route of Administration
Market, By Distribution Channel
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →